Skip to content
Search

Latest Stories

SPONSORED: Sensodyne launches new product to extend its sensitivity and gum range

Sensodyne, the number one dentist recommended toothpaste brand for sensitive teeth[1], is expanding its Sensitivity & Gum range with a product that helps to strengthen tooth enamel. The new Sensodyne Sensitivity Gum & Enamel toothpaste will help to improve gum health and strengthen enamel, leaving consumers with a more confident smile.

Gum problems and enamel wear are two leading causes of sensitive teeth. Gum problems are caused by a build-up of plaque bacteria, while enamel wear can be caused by acids in everyday food and drinks. The Sensodyne Sensitivity Gum & Enamel toothpaste is formulated to provide Daily Triple Action, helping to protect sensitive teeth, neutralise plaque bacteria for healthier gums and strengthen enamel. The new Micro Foam formula targets and removes plaque bacteria in hard-to-reach places between the teeth and along the gumline, helping to restore gum health.


Dr Kate Fabrikant, Medical Lead Northern Europe, Haleon, said: “Following the launch of our existing Sensitivity & Gum toothpastes, we are introducing the new Sensitivity Gum & Enamel toothpaste. The new toothpaste provides Daily Triple Action, helping to strengthen enamel, which can be damaged by consuming acidic food and drink like citrus or coffee, as well as protecting sensitive teeth and improving gum health.

“Acid erosion is common, yet so many people are unaware of the effect it can have on our smile. We hope that with the launch of Sensitivity Gum & Enamel, we can encourage consumers to care for their sensitive teeth and gum problems, while strengthening their tooth enamel, with just one product.”

The new Sensodyne toothpaste helps to maintain strong, healthy teeth and gums, while the mint flavour leaves an extra fresh feeling in the mouth, providing a soothing and cooling sensation on the gums. The product is now available in high pharmacies.

References:

[1] *64% of 200 surveyed dentists, 2022 (contact mystory.gb@haleon.com for claim verification)

More For You

GP surgery upgrades for annual appointments

The surgeries will have additional space to “see more patients, boost productivity and improve patient care”

Pic credit: iStock

GP surgery upgrades to create 8.3 million more annual appointments

Over 1,000 GP surgeries will have their premises modernised to meet the needs of a further 8.3 million appointments each year, the government has announced.

Backed by a cash injection of over £102 million, the surgeries will have additional space to “see more patients, boost productivity and improve patient care”.

Keep ReadingShow less
Wales boosts funding for pharmacy-led UTI and sore throat test services

The sore throat test (STTT) and treat service will be widely available

Pic credit: istock

Welsh pharmacies receive funding boost for clinical services

Two key clinical services will be available in 99 per cent of community pharmacies across Wales after a boost in funding.

The sore throat test (STTT) and treat service and the urinary tract infection (UTI) service have both benefitted from contractual negotiations between the Welsh Government and Community Pharmacy Wales (CPW).

Keep ReadingShow less
Paul Bennett
Paul Bennett, CEO, Royal Pharmaceutical Society
Paul Bennett, CEO, Royal Pharmaceutical Society

Pharmacists need to take advantage of independent prescribing pathways, says Bennett

Independent prescribing will be a “significant point” in the history of community pharmacy, according to Royal Pharmaceutical Society chief executive Paul Bennett.

Last month, the RPS announced the launch of a comprehensive new prescribing development programme to support pharmacists across all stages of their prescribing careers.

Keep ReadingShow less
Community Pharmacy Scotland secures £10m reimbursement uplift amid ongoing negotiations

Negotiations continue on the Global Sum element of remuneration.

Getty Images

Community Pharmacy Scotland secures £120m reimbursement deal for 2025/26

Community Pharmacy Scotland (CPS) has accepted the Scottish government’s initial financial offer for the 2025/26 fiscal year, securing a guaranteed minimum reimbursement of £120 million for community pharmacies — up from £110 million from 2024/25.

The agreement marks the first phase of ongoing negotiations surrounding community pharmacy funding for the upcoming financial year.

Keep ReadingShow less